Company Filing History:
1 out of 785 
1 out of 1 
1 out of 987 
Years Active: 2007
Title: Innovations of James Patrick Synder in Anticancer Research
Introduction
James Patrick Synder is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His innovative work focuses on creating conformationally constrained paclitaxel analogs, which have shown promise in treating cancer and Alzheimer's disease.
Latest Patents
One of Synder's notable patents is titled "Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimer's agents." This patent describes constrained paclitaxel derivatives that include a bridge extending from the C-3' phenyl to either the C4 or -3 positions. Many of these constrained paclitaxel derivatives provide activity comparable to or superior to the natural product paclitaxel. He holds 1 patent in this area.
Career Highlights
Throughout his career, Synder has worked with various institutions, including Virginia Tech Intellectual Properties, Inc. and Binghamton University. His research has contributed to advancements in drug development and therapeutic applications.
Collaborations
Synder has collaborated with notable colleagues in his field, including David George Ian Kingston and Thota Ganesh. These partnerships have enhanced his research and expanded the impact of his innovations.
Conclusion
James Patrick Synder's work in developing paclitaxel analogs represents a significant advancement in the fight against cancer and Alzheimer's disease. His innovative approach and collaborations have positioned him as a key figure in medicinal chemistry.